ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2025

FGF1 as a New Promising Therapeutic Target in Type 2 Diabetes: Advances in Research and Clinical Trials.

Tiansheng Bu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.